This inventor holds 1 USPTO granted patent. Top assignee: Key Pharmaceuticals, Inc.. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: Stanton R Deriel: Innovator in Iontophoretic Drug Delivery
Introduction
Stanton R Deriel is a notable inventor based in Pembroke Pines, FL (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent related to iontophoretic technology. His work aims to enhance the effectiveness of drug administration to patients.
Latest Patents
Stanton R Deriel holds a patent for a "Method and apparatus for iontophoretic drug delivery." This invention describes a device designed for the iontophoretic delivery of active ingredients to patients. The device includes an electrode, a first cavity for holding a solution of at least partially active ingredients in ionizing form, and a member that maintains the solution while allowing the passage of the active ingredient. Additionally, it features an ion exchange member that separates the electrode from the first cavity, inhibiting the flow of ions with a similar charge to that of the ionized active ingredient. This innovative approach provides a method for effectively delivering active ingredients to patients.
Career Highlights
Stanton R Deriel is associated with Key Pharmaceuticals, Inc., where he continues to develop and refine his inventions. His work in the pharmaceutical industry has positioned him as a key player in advancing drug delivery technologies.
Collaborations
Stanton has collaborated with John E Sanderson, contributing to the development of innovative solutions in the field of drug delivery.
Conclusion
Stanton R Deriel's contributions to iontophoretic drug delivery represent a significant advancement in medical technology. His innovative approach has the potential to improve patient care through more effective drug administration methods.